NCT05958719
- Conditions
- Epigenetic Repression, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
- Locations
-
- Institute of Hematology & Blood Diseases Hospital Tianjin, Tianjin Municipality, China
Clinical trial condition
Lymphoma, T-Cell, Peripheral
Explore clinical trials studying Lymphoma, T-Cell, Peripheral. Study availability and eligibility vary by location and protocol.
239 public trials
60 recruiting studies
Lymphoma, T-Cell, Peripheral trial results
NCT06739265
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Peking Union Medical College Hospital Beijing, China
NCT05934513
- Conditions
- Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
- Locations
-
- Sun Yat-sen University Cancer Center Guanzhou, Guangdong, China
NCT06176027
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
- Locations
-
- Navy General Hospital Beijing, Beijing Municipality, China
Recruiting
RIC With Thiotepa Combined With Bu/Flu/Ara-C in Allo-HSCT for Relapsed or Refractory PTCL.
NCT06468267
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Shanghai General Hospital Shanghai, Shanghai Municipality, China
NCT06509945
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Shanghai General Hospital Shanghai, Shanghai Municipality, China
NCT05675813
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Ruijin hospital Shanghai, Shanghai Municipality, China
NCT05444712
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Chu D'Amiens - Hopital Sud Amiens, France
- Chu D'Angers Angers, France
- Ch Victor Dupouy Argenteuil, France
- Ch D'Avignon - Hopital Henri Duffaut Avignon, France
Recruiting
Go-CHOP as the Frontline Therapy for PTCL
NCT05963347
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Henan Cancer Hospital Zhengzhou, Henan, China
NCT04922567
- Conditions
- CHOP, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
- Locations
-
- 2nd Affiliated Hospital, School of Medicine, Zhejiang University Hangzhou, Zhejiang, China